mRNA 1018
Alternative Names: mRNA-1018; Pandemic flu vaccine - Moderna Therapeutics; Pandemic influenza vaccine - Moderna TherapeuticsLatest Information Update: 09 Jul 2024
At a glance
- Originator Moderna Therapeutics
- Class Influenza virus vaccines; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Influenza virus infections
Most Recent Events
- 02 Jul 2024 Moderna Therapeutics plans a phase III trial for Influenza virus infections
- 10 Jul 2023 Phase-I/II clinical trials in Influenza virus infections (Prevention) in USA (IM) (NCT05972174)
- 04 May 2023 Preclinical trials in Influenza virus infections (Prevention) in USA (Parenteral) prior to May 2023